Your browser doesn't support javascript.
loading
Combination of bortezomib plus ruxolitinib in steroid-refractory chronic graft-versus-host disease.
Kaloyannidis, Panayotis; Shaibani, Eshrak Al; Apostolidis, Ioannis; Kanfar, Solaf; Anezi, Khalid Al; Hashmi, Hani Al.
Afiliación
  • Kaloyannidis P; Adults Hematology and Stem Cell Transplantation Department, King Fahad Specialist Hospital, Dammam, Saudi Arabia. pkaloyannidis@yahoo.gr.
  • Shaibani EA; Adults Hematology and Stem Cell Transplantation Department, King Fahad Specialist Hospital, Dammam, Saudi Arabia.
  • Apostolidis I; Adults Hematology and Stem Cell Transplantation Department, King Fahad Specialist Hospital, Dammam, Saudi Arabia.
  • Kanfar S; Adults Hematology and Stem Cell Transplantation Department, King Fahad Specialist Hospital, Dammam, Saudi Arabia.
  • Anezi KA; Adults Hematology and Stem Cell Transplantation Department, King Fahad Specialist Hospital, Dammam, Saudi Arabia.
  • Hashmi HA; Adults Hematology and Stem Cell Transplantation Department, King Fahad Specialist Hospital, Dammam, Saudi Arabia.
Bone Marrow Transplant ; 54(5): 746-748, 2019 05.
Article en En | MEDLINE | ID: mdl-30337698
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pirazoles / Bortezomib / Enfermedad Injerto contra Huésped Tipo de estudio: Etiology_studies Límite: Adult / Humans / Male Idioma: En Revista: Bone Marrow Transplant Asunto de la revista: TRANSPLANTE Año: 2019 Tipo del documento: Article País de afiliación: Arabia Saudita
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pirazoles / Bortezomib / Enfermedad Injerto contra Huésped Tipo de estudio: Etiology_studies Límite: Adult / Humans / Male Idioma: En Revista: Bone Marrow Transplant Asunto de la revista: TRANSPLANTE Año: 2019 Tipo del documento: Article País de afiliación: Arabia Saudita